Fabris Paolo, Baldo Vincenzo, Baldovin Tatjana, Bellotto Emanuela, Rassu Mario, Trivello Renzo, Tramarin Andrea, Tositti Giulia, Floreani Annarosa
Department of Infectious Diseases and Tropical Medicine, S. Bortolo Hospital, Vicenza, Italy.
J Clin Gastroenterol. 2008 May-Jun;42(5):527-32. doi: 10.1097/MCG.0b013e318030e3ab.
To evaluate the hepatitis B virus (HBV) and the hepatitis C virus (HCV) epidemiology in the general population of Northern Italy, a cohort of 965 subjects, all residents (including 47 immigrants), were anonymously tested for HBV and HCV infections.
Serum samples were assayed for anti-HCV and anti-HBV markers by enzyme-linked immunosorbent assay and for HCV-RNA by polymerase chain reaction, and the positive cases were genotyped. HBsAg-positive cases were assayed for HBeAg/anti-HBe, whereas HBsAg negatives were tested for both anti-HBc and anti-HBs.
The overall prevalence of anti-HCV was 2.6%, with a bimodal distribution characterized by the highest prevalence (12%) in subjects over 75 years old. None of the subjects under 25 years old was anti-HCV positive. Anti-HCV positivity was similar in males and females (2.4% vs. 2.7%). HCV-RNA was positive in 40% of cases and genotype 1 was the most common. The HBsAg prevalence was 1%, with a significant difference according to country of origin (0.8% in Italian subjects vs. 6.4% in immigrants, P=0.01). HBsAg positivity increased significantly with age (R2=0.57, P<0.02). The overall percentages for the prevalence of isolated anti-HBs, anti-HBs+/anti-HBc+, and isolated anti-HBc were 23.8%, 8.4%, and 4.2%, respectively.
Our study provides a new picture of HCV and HBV epidemiology in Northern Italy, with these features: (1) a cohort effect showing a reduction of HCV infection in the elderly, possible due to age-related mortality; (2) an unchanged overall prevalence of HBV infection, despite continuing immigration of subjects from endemic countries.
评估意大利北部普通人群中的乙型肝炎病毒(HBV)和丙型肝炎病毒(HCV)流行病学情况,对965名受试者(包括47名移民)进行了匿名的HBV和HCV感染检测,所有受试者均为当地居民。
采用酶联免疫吸附试验检测血清样本中的抗-HCV和抗-HBV标志物,采用聚合酶链反应检测HCV-RNA,并对阳性病例进行基因分型。对HBsAg阳性病例检测HBeAg/抗-HBe,对HBsAg阴性病例检测抗-HBc和抗-HBs。
抗-HCV的总体患病率为2.6%,呈双峰分布,75岁以上人群患病率最高(12%)。25岁以下的受试者中无一例抗-HCV阳性。抗-HCV阳性在男性和女性中相似(2.4%对2.7%)。40%的病例HCV-RNA呈阳性,基因型1最为常见。HBsAg患病率为1%,根据原籍国存在显著差异(意大利受试者中为0.8%,移民中为6.4%,P=0.01)。HBsAg阳性率随年龄显著增加(R2=0.57,P<0.02)。单独抗-HBs、抗-HBs+/抗-HBc+和单独抗-HBc的总体患病率分别为23.8%、8.4%和4.2%。
我们的研究提供了意大利北部HCV和HBV流行病学的新情况,具有以下特点:(1)队列效应显示老年人中HCV感染减少,可能是由于与年龄相关的死亡率;(2)尽管来自流行国家的受试者持续移民,但HBV感染的总体患病率未变。